DE602004013787D1 - Bioadhäsives gel auf basis von hydroxyethylcellulose - Google Patents

Bioadhäsives gel auf basis von hydroxyethylcellulose

Info

Publication number
DE602004013787D1
DE602004013787D1 DE602004013787T DE602004013787T DE602004013787D1 DE 602004013787 D1 DE602004013787 D1 DE 602004013787D1 DE 602004013787 T DE602004013787 T DE 602004013787T DE 602004013787 T DE602004013787 T DE 602004013787T DE 602004013787 D1 DE602004013787 D1 DE 602004013787D1
Authority
DE
Germany
Prior art keywords
hydroxyethyl cellulose
bioadhesive gel
gel based
bioadhesive
hydroxyethylcellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004013787T
Other languages
English (en)
Inventor
Massimo Prini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitech Idea SRL
Original Assignee
Mipharm SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mipharm SpA filed Critical Mipharm SpA
Publication of DE602004013787D1 publication Critical patent/DE602004013787D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
DE602004013787T 2003-08-08 2004-07-30 Bioadhäsives gel auf basis von hydroxyethylcellulose Active DE602004013787D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001640A ITMI20031640A1 (it) 2003-08-08 2003-08-08 Base per gel bioadesivi.
PCT/EP2004/008577 WO2005014047A1 (en) 2003-08-08 2004-07-30 Bioadhesive gel based on hydroxyethylcellulose

Publications (1)

Publication Number Publication Date
DE602004013787D1 true DE602004013787D1 (de) 2008-06-26

Family

ID=34131212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004013787T Active DE602004013787D1 (de) 2003-08-08 2004-07-30 Bioadhäsives gel auf basis von hydroxyethylcellulose

Country Status (16)

Country Link
US (2) US20070031479A1 (de)
EP (1) EP1651274B1 (de)
JP (1) JP4855935B2 (de)
CN (1) CN1832760B (de)
AT (1) ATE395084T1 (de)
BR (1) BRPI0413446A (de)
CA (1) CA2535123C (de)
CY (1) CY1108548T1 (de)
DE (1) DE602004013787D1 (de)
DK (1) DK1651274T3 (de)
ES (1) ES2305818T3 (de)
IT (1) ITMI20031640A1 (de)
PL (1) PL1651274T3 (de)
PT (1) PT1651274E (de)
SI (1) SI1651274T1 (de)
WO (1) WO2005014047A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100394919C (zh) * 2006-03-01 2008-06-18 杨军 一种用于治疗阴道疾病的药物组合物
US8433851B2 (en) 2007-08-16 2013-04-30 International Business Machines Corporation Reducing wiring congestion in a cache subsystem utilizing sectored caches with discontiguous addressing
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) * 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN106310266A (zh) * 2015-07-09 2017-01-11 王强 一种预防或治疗粘膜疾病的组合物及制备方法
CN106109398A (zh) * 2016-06-14 2016-11-16 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶
CN106038477A (zh) * 2016-06-14 2016-10-26 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶的制备方法
LT3481370T (lt) * 2016-07-08 2021-08-25 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Farmacinė kompozicija, apimanti benzidaminą
IT201900000388A1 (it) * 2019-01-10 2020-07-10 L N Age S R L Composizione per l'uso nel trattamento di lesioni vaginali, del glande ed anali
CN114096237A (zh) * 2019-06-21 2022-02-25 阿尔法西格玛有限公司 用于活性成分控释的包含木葡聚糖和醇的凝胶形式的药物组合物
CN111557897B (zh) * 2020-07-07 2023-06-23 温州海鹤药业有限公司 一种含有硝呋太尔的药物组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
JPH04217925A (ja) * 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
JP3616688B2 (ja) * 1996-03-25 2005-02-02 太田製薬株式会社 医薬組成物
AU3306997A (en) * 1996-06-12 1998-01-07 Procter & Gamble Company, The Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
US5871715A (en) * 1997-02-28 1999-02-16 Gillette Canada Inc. Stannous fluoride gel with improved stand-up
WO1998051283A1 (en) * 1997-05-14 1998-11-19 Galen (Chemicals) Limited Topical compositions
US6982091B2 (en) * 2001-08-29 2006-01-03 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
AU3565799A (en) 1998-09-17 2000-04-03 Zonagen, Inc. Methods and materials related to bioadhesive contraceptive gels
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
JP2003512310A (ja) * 1999-10-22 2003-04-02 リーフ−フラウプ イーエイチエフ バイオ−ゲルズ ファーマシューティカルス インコーポレイテッド 粘膜上皮潰瘍および/または糜爛の治療用製薬組成物
FR2802097B1 (fr) 1999-12-14 2002-12-13 Invest S Therapeutiques Essais Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
KR100856523B1 (ko) * 2000-08-03 2008-09-04 안타레스 파르마 아이피엘 에이쥐 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
WO2003066001A2 (en) * 2002-02-07 2003-08-14 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina

Also Published As

Publication number Publication date
CA2535123C (en) 2012-06-26
US8790685B2 (en) 2014-07-29
CN1832760B (zh) 2010-06-23
CA2535123A1 (en) 2005-02-17
ITMI20031640A1 (it) 2005-02-09
JP4855935B2 (ja) 2012-01-18
SI1651274T1 (sl) 2008-10-31
DK1651274T3 (da) 2008-09-08
ATE395084T1 (de) 2008-05-15
CN1832760A (zh) 2006-09-13
BRPI0413446A (pt) 2006-10-17
US20120083515A1 (en) 2012-04-05
CY1108548T1 (el) 2014-04-09
JP2007533604A (ja) 2007-11-22
PL1651274T3 (pl) 2008-10-31
WO2005014047A1 (en) 2005-02-17
EP1651274B1 (de) 2008-05-14
ES2305818T3 (es) 2008-11-01
EP1651274A1 (de) 2006-05-03
US20070031479A1 (en) 2007-02-08
PT1651274E (pt) 2008-08-11

Similar Documents

Publication Publication Date Title
CY1108548T1 (el) Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
ATE476450T1 (de) Vernetzte polysaccharidzusammensetzung
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
DE50312034D1 (de) Liposomale glucocorticoide
BR0113286B1 (pt) pirazàis substituÍdos e composiÇço farmacÊutica compreendendo os mesmos.
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
PE3296A1 (es) Composicion oral conteniendo un mucoadhesivo
AR038026A1 (es) Gel que comprende al menos un retinoide y peroxido de benzoilo
NO20001567L (no) Bioadhesive sammensetninger og fremgangsmÕter for topisk administrering av aktive midler
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
RS52504B (en) TRANSMUCOSE VETERINARY MIXTURE CONTAINING DETOMIDINE
DE60142031D1 (de) Viskoelastische substanzen zur verwendung bei mittelohr operationen
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
CY1106227T1 (el) Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου
WO2003066597A3 (en) Guanidino compounds
DE60140997D1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
BRPI0611526A2 (pt) composição tópica contendo gelatina
SE9602644D0 (sv) New use
SE0001916D0 (sv) Novel formulation
PE20050359A1 (es) Composiciones topicas que comprenden terbinafina e hidrocortisona
ATE336987T1 (de) Gelzubereitung enthaltend einen gelösten oder suspendierten wirkstoff,insbesondere zur anwendung auf einer schleimhaut und herstellungsverfahren
EA200100197A1 (ru) Глазной антисептик
UA68381C2 (en) Spermicidal substance and vaginal contraceptive

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MITECH-IDEA S.R.L., MILANO, IT

8364 No opposition during term of opposition